Carboxylesterase1/Esterase-x Regulates Chylomicron Production in Mice

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Quiroga, Ariel D ^a   Lian, Jihong ^a   Lehner, Richard ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLESTERASE; CARBOXYLESTERASE1; CHYLOMICRON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CES1 GENE; DIETARY INTAKE; FEMALE; GENE EXPRESSION; HYPERLIPIDEMIA; INTESTINAL LIPID METABOLISM; INTESTINE CELL; JEJUNUM; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIPOPROTEIN SECRETION; MOUSE; NONHUMAN; PLASMA CLEARANCE; POSTPRANDIAL STATE; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; REGULATORY MECHANISM;

ANIMALS; CARBOXYLIC ESTER HYDROLASES; CHYLOMICRONS; ESTERASES; FEMALE; HYPERLIPIDEMIAS; JEJUNUM; LIPID METABOLISM; MICE;

MUS;

EID: 84868709755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049515     Document Type: Article

References (29)

1. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A, (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298: 299-308.
2. Goldberg IJ, Eckel RH, McPherson R, (2011) Triglycerides and heart disease: still a hypothesis? Arterioscler Thromb Vasc Biol 31: 1716-1725.
3. Quiroga AD, Li L, Trotzmuller M, Nelson R, Proctor SD, et al. (2012) Deficiency of carboxylesterase 1/esterase-x in mice results in obesity, hepatic steatosis and hyperlipidemia. Hepatology. doi: 10.1002/hep.25961.
4. Wei E, Ben Ali Y, Lyon J, Wang H, Nelson R, et al. (2010) Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. Cell Metab 11: 183-193.
5. Yen CL, Cheong ML, Grueter C, Zhou P, Moriwaki J, et al. (2009) Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding. Nat Med 15: 442-446.
6. Bharadwaj KG, Hiyama Y, Hu Y, Huggins LA, Ramakrishnan R, et al. (2010) Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake. J Biol Chem 285: 37976-37986.
7. Fielding CJ, Fielding PE, (1976) Chylomicron protein content and the rate of lipoprotein lipase activity. J Lipid Res 17: 419-423.
8. Werner A, Havinga R, Perton F, Kuipers F, Verkade HJ, (2006) Lymphatic chylomicron size is inversely related to biliary phospholipid secretion in mice. Am J Physiol Gastrointest Liver Physiol 290: G1177-1185.
9. Cartwright IJ, Higgins JA, (1999) Isolated rabbit enterocytes as a model cell system for investigations of chylomicron assembly and secretion. J Lipid Res 40: 1357-1365.
10. Wang LC, Nassir F, Liu ZY, Ling L, Kuo F, et al. (2002) Disruption of hedgehog signaling reveals a novel role in intestinal morphogenesis and intestinal-specific lipid metabolism in mice. Gastroenterology 122: 469-482.
11. Schwarz M, Lund EG, Setchell KD, Kayden HJ, Zerwekh JE, et al. (1996) Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. J Biol Chem 271: 18024-18031.
12. Ma T, Jayaraman S, Wang KS, Song Y, Yang B, et al. (2001) Defective dietary fat processing in transgenic mice lacking aquaporin-1 water channels. Am J Physiol Cell Physiol 280: C126-134.
13. Cooper AD, (1997) Hepatic uptake of chylomicron remnants. J Lipid Res 38: 2173-2192.
14. Yu KC, Cooper AD, (2001) Postprandial lipoproteins and atherosclerosis. Front Biosci 6: D332-354.
15. Herz J, Qiu SQ, Oesterle A, DeSilva HV, Shafi S, et al. (1995) Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc Natl Acad Sci U S A 92: 4611-4615.
16. Ishibashi S, Perrey S, Chen Z, Osuga J, Shimada M, et al. (1996) Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both. J Biol Chem 271: 22422-22427.
17. Gilham D, Ho S, Rasouli M, Martres P, Vance DE, et al. (2003) Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion. FASEB J 17: 1685-1687.
18. Ko KW, Erickson B, Lehner R, (2009) Es-x/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes. Biochim Biophys Acta 1791: 1133-1143.
19. Tso P, Balint JA, Bishop MB, Rodgers JB, (1981) Acute inhibition of intestinal lipid transport by Pluronic L-81 in the rat. Am J Physiol 241: G487-497.
20. Rensen PC, van Berkel TJ, (1996) Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem 271: 14791-14799.
21. Fojo SS, Brewer HB, (1992) Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Intern Med 231: 669-677.
22. Huang Y, Liu XQ, Rall SC Jr, Taylor JM, von Eckardstein A, et al. (1998) Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem 273: 26388-26393.
23. Martins IJ, Mortimer BC, Miller J, Redgrave TG, (1996) Effects of particle size and number on the plasma clearance of chylomicrons and remnants. J Lipid Res 37: 2696-2705.
24. Tajima S, Yokoyama S, Yamamoto A, (1983) Effect of lipid particle size on association of apolipoproteins with lipid. J Biol Chem 258: 10073-10082.
25. Chajek-Shaul T, Eisenberg S, Oschry Y, Olivecrona T, (1983) Metabolic heterogeneity of post-lipolysis rat mesenteric lymph small chylomicrons produced in vitro. J Lipid Res 24: 831-840.
26. Guldur T, Mayes PA, (1992) Metabolic comparison of small chylomicrons (intestinal VLDL) and large chylomicrons. Biochem Soc Trans 20: 104S.
27. Quarfordt SH, Goodman DS, (1966) Heterogeneity in the rate of plasma clearance of chylomicrons of different size. Biochim Biophys Acta 116: 382-385.
28. Wang F, Kohan AB, Kindel TL, Corbin KL, Nunemaker CS, et al. (2012) Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion. Proc Natl Acad Sci U S A 109: 9641-9646.
29. Iqbal J, Dai K, Seimon T, Jungreis R, Oyadomari M, et al. (2008) IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA. Cell Metab 7: 445-455.